Applying new clinicopathological characteristics to prognostication in advanced thyroid carcinoma.
作者:
Cabanillas(Maria E),Sherman(Steven I)
状态:
发布时间2012-04-12
, 更新时间 2016-10-25
期刊:
Endocr Relat Cancer
摘要:
In the February 2011 issue of Endocrine-Related Cancer, Deandreis et al. reported that increased FDG uptake was prognostic in patients with metastatic thyroid cancer. Fludeoxyglucose-positron emission tomography (FDG-PET) is routinely used in the staging and follow-up of patients with cancer. This study gives further evidence for the role of FDG-PET scanning in metastatic thyroid cancer, especially to identify patients with aggressive disease requiring systemic therapy.